SURVIVAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATMENT WITH 5-AZACITIDINE: EXPERIENCE OF A CENTER

被引：0
|
作者：
Busnego, M. T. [1 ]
Sanchez, A. [1 ]
Notario, C. [1 ]
Cabello, A. [1 ]
Oliva, A. [1 ]
Brena, J. [1 ]
Alberich, M. P. [1 ]
Gonzalez, H. [1 ]
Marrero, C. [1 ]
Rios, P. [1 ]
Figueroa, A. [1 ]
Hernanz, N. [1 ]
Rios, M. [1 ]
Leon, A. [1 ]
Hernandez, P. [1 ]
Hillebrand, P. [1 ]
Uribe, L. [1 ]
Mesa, M. C. [1 ]
机构：
[1] Hosp Univ Nuestra Senora Candelaria, Santa Cruz de La Palma, Spain
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-049
引用
收藏
页码：424 / 424
页数：1
相关论文
共 50 条
  • [41] Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry
    Pleyer, Lisa
    Burgstaller, Sonja
    Stauder, Reinhard
    Girschikofsky, Michael
    Linkesch, Werner
    Pfeilstoeker, Michael
    Autzinger, Eva Maria
    Tinchon, Christoph
    Sliwa, Thamer
    Lang, Alois
    Sperr, Wolfgang R.
    Geissler, Dietmar
    Krippl, Peter
    Voskova, Daniela
    Rossmann, Dieter H.
    Schlick, Konstantin
    Thaler, Josef
    Halter, Britta
    Machherndl-Spandl, Sigrid
    Theiler, Georg
    Valent, Peter
    Eckmuellner, Otto
    Greil, Richard
    BLOOD, 2014, 124 (21)
  • [42] Real World Outcomes of Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia: A Single Center Experience
    Zahra, Fatima Tuz
    Ong, Faustine
    Walgenbach, Daniel
    Chan, Onyee
    Tobon, Katherine
    Lancet, Jeffrey E.
    Sallman, David
    Komrokji, Rami S.
    Kuykendall, Andrew T.
    Padron, Eric
    Walker, Alison R.
    Xie, Zhuoer
    Yun, Seongseok
    BLOOD, 2024, 144 : 2415 - 2416
  • [43] RESULTS OF THE USE OF 5-AZACITIDINE IN OLD PATIENTS DIAGNOSED OF CHRONIC MYELOMONOCYTIC LEUKEMIA
    Llorente Dunia, De Miguel
    Lopez Nuria, Golbano
    Morfa Miguel, Diaz
    Juanis Jaime, Arbeteta
    Sanz Dolores, Morales
    Martin Sonia, Herreo
    Perez Dolores, Subira
    Albiz Blanca, Pinedo
    HAEMATOLOGICA, 2016, 101 : 344 - 344
  • [44] Epigenetic therapy with 5-azacitidine in a treatment schedule of five days every 4 weeks induces hematologic responses in patients with acute myeloid leukemia refractory to or not eligible for intensive chemotherapy
    Al-Ali, H. K.
    Schwind, S.
    Krahl, R.
    Becker, C.
    Leiblein, S.
    Mueller, C.
    Niederwieser, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 7 - 7
  • [45] A UK single centre experience of 5-azacitidine in patients with myeloid malignancies, prior to NICE approval - a retrospective evaluation of 113 patients
    Kulasekararaj, A. G.
    Patel, S.
    Skwarski, M.
    Krishnamurthy, P.
    Ireland, R. I.
    Marsh, J.
    Hayden, J.
    Mufti, G. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 65 - 65
  • [46] ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS NOT CONSIDERED FIT FOR INTENSIVE TREATMENT; AZACITIDINE, LOW DOSE CYTARABINE AND ETOPOSID COMBINATION EXPERIENCE FROM A SINGLE CENTER
    Okutan, H.
    Onec, B.
    Albayrak, M.
    Aslan, V.
    Can, E.
    Kosemehmetoglu, O.
    Koluman, B.
    Albayrak, A.
    HAEMATOLOGICA, 2013, 98 : 531 - 531
  • [47] CLINICAL EFFICACY OF THE COMBINATION OF SECOND GENERATION TYROSINE KINASE INHIBITORS AND 5-AZACITIDINE IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA PATIENT IN MYELOID BLAST CRISIS
    Vlasova, Yu. Yu
    Morozova, E., V
    Smirnova, A. G.
    Gindina, T. L.
    Afanasiev, B., V
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2016, 61 (04): : 215 - 217
  • [48] EXPERIENCE OF A TERTIARY CENTER IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA IN THE ELDERLY PATIENT
    Martin Martitegui, X.
    Balerdi Malcorra, A.
    Amutio Diez, E.
    Gomez Perez, C.
    Posada Alcon, L.
    Arzuaga Mendez, J.
    Garcia Ruiz, J. C.
    HAEMATOLOGICA, 2017, 102 : 168 - 169
  • [49] Outcomes of Acute Myeloid Leukemia Patients Suffering from an Additional Active Malignancy Treated with Venetoclax and Azacitidine: A Single Center Experience
    Moshe, Yakir
    Levi, Shai
    Neaman, Miriam
    Gat, Roi
    Levi, Mor
    Eilati, Nili
    Fridberg, Gil
    Bornstein, Yotam
    Shragai, Tamir
    Neuman, Tsipora
    Vitkon, Roy
    Shachar, Eliya
    Sarid, David
    Merimsky, Ofer
    Mittelman, Moshe
    Mazza, Irit Avivi
    BLOOD, 2023, 142
  • [50] ANALYSIS OF THE EFFECTIVENESS OF THE USE OF AZACITIDINE-VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN RECOVERY / REFRACTORY: EXPERIENCE IN OUR CENTER
    Ma Victoria, Verdugo Cabeza De Vaca
    Plaza Virginia, Olivencia
    Prados Clara, Garrido
    Cuenca Araceli, Salamanca
    HAEMATOLOGICA, 2021, 106 (10) : 213 - 214
12345